10-K
Annual Report
Autonomix Medical, Inc.
AMIX
NASDAQ
CIK: 1617867
File #: 001-41940
Balance Sheet
24 line items · 2 periods
XBRL
| Item | Mar 31, 2026 | Mar 31, 2025 |
|---|---|---|
Current assets: | ||
Cash and cash equivalents | 7,004,000 | 9,136,000 |
Other current assets | 577,000 | 473,000 |
Total current assets | 7,581,000 | 9,609,000 |
Noncurrent assets: | ||
Property and equipment, net | 19,000 | 21,000 |
Deferred offering costs | 0 | 176,000 |
Total noncurrent assets | 19,000 | 197,000 |
Total Assets | 7,600,000 | 9,806,000 |
Current liabilities: | ||
Accounts payable | 700,000 | 676,000 |
Accrued expenses | 1,005,000 | 1,031,000 |
Total current liabilities | 1,705,000 | 1,707,000 |
Total Liabilities | 1,705,000 | 1,707,000 |
Stockholders' equity: | ||
Preferred stock, $0.001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of March 31, 2026 and 2025, respectively | 0 | 0 |
Common stock, $0.001 par value, 500,000,000 shares authorized, 11,409,344 and 2,497,033 shares issued and outstanding as of March 31, 2026 and 2025, respectively | 11,000 | 2,000 |
Additional paid-in capital | 72,978,000 | 58,476,000 |
Accumulated deficit | (67,094,000) | (50,379,000) |
Total Stockholders' Equity | 5,895,000 | 8,099,000 |
Common Stock | 11,000 | 2,000 |
Additional Paid-in Capital | 72,978,000 | 58,476,000 |
Retained Earnings | (67,094,000) | (50,379,000) |
Total Liabilities and Stockholders' Equity | 7,600,000 | 9,806,000 |